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Abstract
Background: CXCR7 (RDC1), the recently discovered second receptor for CXCL12, is phylogenetically closely related to
chemokine receptors, but fails to couple to G-proteins and to induce typical chemokine receptor mediated cellular
responses. The function of CXCR7 is controversial. Some studies suggest a signaling activity in mammalian cells and
zebrafish embryos, while others indicate a decoy activity in fish. Here we investigated the two propositions in human
tissues.
Methodology/Principal Findings: We provide evidence and mechanistic insight that CXCR7 acts as specific scavenger for
CXCL12 and CXCL11 mediating effective ligand internalization and targeting of the chemokine cargo for degradation.
Consistently, CXCR7 continuously cycles between the plasma membrane and intracellular compartments in the absence and
presence of ligand, both in mammalian cells and in zebrafish. In accordance with the proposed activity as a scavenger
receptor CXCR7-dependent chemokine degradation does not become saturated with increasing ligand concentrations.
Active CXCL12 sequestration by CXCR7 is demonstrated in adult mouse heart valves and human umbilical vein
endothelium.
Conclusions/Significance: The finding that CXCR7 specifically scavenges CXCL12 suggests a critical function of the receptor
in modulating the activity of the ubiquitously expressed CXCR4 in development and tumor formation. Scavenger activity of
CXCR7 might also be important for the fine tuning of the mobility of hematopoietic cells in the bone marrow and lymphoid
organs.
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Introduction
The chemokine system is indispensable for leukocyte trafficking.
Chemokines attract immune cells via their cognate G-protein
coupled receptors (GPCRs) to sites of inflammation and mediate
homing to lymphoid organs [1]. Among the various constituents of
the chemokine system CXCL12 (SDF-1) and its receptor CXCR4
possess exceptional properties as they control processes outside of
the hematopoietic system. Genetic deletion of either molecule
leads to a similar phenotype in mouse embryos [2–4] that is
characterized by defective lymphopoiesis and myelopoiesis,
imperfect vasculature, abnormal brain and heart development
leading to perinatal death. These findings led to the assumption
that CXCR4 and CXCL12 represent a monogamous receptor-
chemokine pair.
Recently RDC1 (CXCR7) was described as second receptor for
CXCL12 [5]. CXCR7, a heptahelical receptor with strong
phylogenetic similarity to GPCRs [6], was shown to bind
CXCL12 and CXCL11 with high affinity, but fails to induce
typical chemokine responses, such as cell migration and associated
intracellular signal transduction [7,8]. Nonetheless, mice lacking
CXCR7 die perinatally due to heart valve malformation, a
phenotype that is recapitulated in mice conditionally deficient for
CXCR7 in the endothelium [9]. In humans, CXCR7 is expressed
in embryonic neuronal and heart tissue, in hematopoietic cells and
activated endothelium [7,8,10]. Elevated levels of CXCR7
correlate with the aggressiveness of human prostate cancer and
promote growth and metastasis of various mouse tumor models
[11–13]. Some studies suggest active signaling through the
receptor [13,14] or modulation of CXCR4-signaling through
heterodimerization with CXCR7 [9,15]. However, the biochem-
ical mechanisms behind these effects are not well understood.
Additional evidence for a critical role of CXCR7 in embryo-
genesis arose from investigations on zebrafish development. The
receptor is required for efficient migration of different cells such as
the posterior lateral line primordium [16,17], motoneurons in the
hindbrain [18] and the primordial germ cells [19]. Interestingly,
the zebrafish genome contains two genes coding for CXCR7a and
b and also two genes coding for CXCL12a and CXCL12b.
However, expression patterns and functional studies suggest that
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only CXCR7b and CXCL12a are involved in primordial germ
cell migration [20,21]. While Valentin et al. [17] propose active
signaling through CXCR7 for the migration of the lateral-line
primordium, Boldajipour and colleagues suggested that CXCR7b
expressed in somatic cells facilitates the CXCL12/CXCR4-
mediated migration of primordial germ cells by controlling the
level of the chemokine in the environment, thereby contributing to
the formation of a chemotactic gradient [19]. Similarly, in the case
of migration of the lateral line primordium, CXCR7b expression
at the back of the cell cluster was suggested to be responsible for
reduction in the level of CXCL12a at that location and to
contribute to the generation of a chemotactic gradient despite the
uniform expression of cxcl12a RNA [16].
In the present study we unveil the mechanism of action of
CXCR7 in mammalian cells. We observed that CXCR7 cycles
between the plasma membrane and endosomal compartments
both in the presence and the absence of ligand. In the presence of
ligand CXCR7 surface expression is biphasic showing only a
moderate reduction of its cell surface levels after prolonged
incubation, and is accompanied by marked uptake and degrada-
tion of CXCL11 and CXCL12. By contrast, CXCR4 becomes
permanently down-regulated following stimulation with CXCL12
and its internalization proceeds with a minimal degradation of the
chemokine. Furthermore, we show CXCR7-mediated sequestra-
tion of CXCL12 by the endothelium of mouse heart valves and of
human umbilical veins. Taken together, our observations support
the notion and provide mechanistic insights concerning the role of
CXCR7 as a specific scavenger for CXCL12.
Methods
Ethics Statement
Human umbilical cords were obtained from the local hospital
(Ospedale San Giovanni, Bellinzona) with confirmed verbal
consent of the donors. The procedure was approved by the local
ethics committee Comitato Etico Cantonale, CH-6501 Bellinzona.
Animals were bred and treated in accordance with the Swiss
Federal Veterinary Office guidelines. Experiments were approved
by the ‘‘Dipartimento della Sanita´ e della Socialita´’’.
Cell Culture
Madin-Darby canine kidney (MDCK) and HeLa cells were
grown in complete Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), penicillin and
streptomycin. Raji B cells were cultured in RPMI 1640 medium
supplemented with 10% FBS, GlutaMAXTM-I, sodium pyruvate,
non-essential amino acids, penicillin and streptomycin (all
Invitrogen). Human umbilical vein endothelial cells (HUVECs)
prepared and grown as described [22] were kindly provided by B.
Wolff and used at passages 3–4.
Plasmids and Transfections
A CXCR7-DRYLAIV mutant was generated by introducing
site-specific point mutations at amino acids Ser(145) and Thr(147) of
human CXCR7 by PCR (AccuPrimeTM Pfx SuperMix, Invitrogen)
with the following primers: 59–CCGCTACCTCGCCATCGTC-
TACTTCACC, 59–GGTGAAGTAGACGATGGCGAGGTA-
GCGG. The myristoylation/palmitylation motif from the Lck
tyrosine kinase was attached to the N-terminus of mCherry to
generate a plasma membrane marker [23]. All mutations were
confirmed by DNA sequencing. Cells were transfected with
pcDNA3 plasmids encoding the human wild type and mutated
receptors using LipofectamineTM 2000 (Invitrogen), followed by
G418 (Sigma-Aldrich) selection. Surface receptor expression levels
were determined by FACS analysis using saturating amounts of
primary antibodies (15 mg/ml anti-CXCR4 (12G5) and anti-
CXCR7 (9C4)) and secondary antibodies (10 mg/ml Alexa Fluor
488-F(ab9)2 goat anti-mouse IgG).
Receptor Expression on Cell Surface after CXCL12
Incubation
Daudi B cells were incubated in RPMI culture medium
containing 0, 100 or 1000 nM CXCL12, 50 mM cycloheximide,
and washed briefly with 1 M NaCl, 50 mM glycine, pH 3. When
indicated 2 mM bafiloycin A1 (Sigma) in DMSO (0.5% f.c.) was
added. Receptor surface levels at 37uC were monitored over time
by FACS analysis after labeling with anti-CXCR4 (12G5) and
anti-CXCR7 (9C4) and Alexa Fluor 488-F(ab9)2 goat anti-mouse
IgG. In control experiments cells were incubated at 0uC with or
without CXCL12 for 1 hour and washed with PBS or subjected to
an acid wash. After acidic wash chemokines were fully removed
and did not affect antibody binding.
Chemokine Uptake and Degradation
MDCK cells expressing human CXCR7, CXCR7-DRYLAIV,
CXCR4, mock-transfected MDCK, or primary HUVECs were
grown on TranswellH insets (Costar, pore size 8 mm). When the
cells reached confluence the culture medium was changed to
Hank’s balanced salt solution (HBSS) containing 10 mM HEPES,
and 1% BSA. Radio-labeled [125I] CXCL12 (GE Healthcare,
0.25 nM) was added to the apical side of the monolayer for
3 hours at 37uC. To assess uptake and transport of ligand across
the monolayer, both top and bottom contents of the Transwell as
well as cell lysates were collected. Trichloracetic acid (TCA, 10%
f.c.) precipitation was used to distinguish intact (precipitated) from
degraded (TCA soluble) chemokine. The radioactivity of the
samples was quantified using a gamma counter (Packard
Instruments).
Confocal Microscopy of MDCK-CXCR7 Monolayers
MDCK cells expressing human CXCR7 or CXCR4 were
grown on glass bottom dishes. Confluent cells were incubated for
15 min with anti-CXCR7 (11G8 R&D) or anti CXCR4 (MAB173
R&D) in growth medium containing 0.1% saponin followed by
incubation with Alexa Fluor 488-F(ab9)2 goat anti-mouse IgG in
the same medium. After washing the secondary antibodies dishes
were immediately analyzed with a Leica TCS SP5 confocal
microscope.
To monitor ligand-independent antibody uptake, MDCK cells
co-expressing membrane-anchored mCherry fluorescent protein
and human CXCR7 or CXCR4 were grown on glass cover slips.
When confluent, cells were incubated with anti-human CXCR7
(9C4) or anti-human CXCR4 (12G5) for 60 min at 37uC.
Location of the primary antibody was revealed with Alexa Fluor
488-F(ab9)2 goat anti-mouse IgG after fixing for 5 min in 4%
paraformaldehyde and permeabilizing the cells with 0.02%
Tween20. Slides were washed with PBS-Tween20 (0.02%) and
incubated for 30 min with Alexa Fluor 488-F(ab9)2 goat anti-
mouse IgG, Alexa Fluor 594 phalloidin (both Invitrogen) and
DAPI. Mounted slides were viewed with a Leica TCS SP5
confocal microscope.
Receptor Re-Expression at the Cell Surface
MDCK cell and Daudi surface molecules were cleaved by
proteinase K (0.1 mg/ml in PBS) for 3 hours on ice before transfer
to PBS, 2% FBS, 2 mM EDTA, 50 mM cycloheximide. Receptor
surface re-expression at 37uC was monitored over time by FACS
CXCR7 Scavenges CXCL12
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analysis using antibodies recognizing the extracellular C-terminus
of the transferrin receptor (OKT9), and the extracellular N-
termini of CXCR4 (6H8) [24] and CXCR7 (9C4) [5] and
secondary Alexa Fluor 488-F(ab9)2 goat anti-mouse IgG.
mRNA Expression Constructs for Zebrafish
The construct used for global expression of CXCR7-EGFP was
generated by cloning the cxcr7-egfp ORF into the pSP64TS vector
that contains 59 and 39 UTRs of the Xenopus globin gene. Capped
sense mRNA was synthesized using the mMessageMachine kit
(Ambion) according to the manufacturer’s instructions.
Microinjections for Global Expression and Knockdown in
Zebrafish Embryos
RNA and morpholino antisense oligonucleotides were microin-
jected into the yolk of one-cell stage embryos. For global expression
of CXCR7 225 pg of cxcr7-egfp-globin mRNA were injected.
Knockdown of both zebrafish CXCL12 versions was achieved using
0.4 pmol of oligonucleotides against cxcl12a (59–TTGAGATC-
CATGTTTGCAGTGTGAA-39), and cxcl12b (59-TTGCTATC-
CATGCCAAGAGCGAGTG-39)
Spinning Disk Confocal Microscopy of Zebrafish Embryos
Confocal fluorescence images were obtained using a Zeiss
AxioImager.M1 microscope fitted with a CascadeII camera
(Photometrics) and VS-Laser Control, all controlled by VisiView
software (Visitron Systems).
Confocal Microscopy of Chemokine Uptake in Human
Umbilical Cords and Mouse Hearts
Sections of 3–5 mm thickness of fresh human umbilical cords
were placed in DMEM containing 1% human albumin, 200 nM
fluorescent chemokine or PBS. When indicated, 10 mM
AMD3100 (Sigma) or 1.5 mM CXCL11 were added to the
medium. After 30 min incubation the sections were washed in
DMEM and mounted in O.C.T. compound (VWR). Cryosections
of 20 mm were fixed for 10 min in 4% paraformaldehyde, washed
in PBST, and incubated for 1 h with anti-human CD31 (BD
Biosciences) in PBST, 1% goat serum (Dako). Slides were washed
with PBST and incubated for 1 h with Alexa Fluor 594-F(ab9)2
goat anti-mouse IgG (Invitrogen) and DAPI. Recombinant
fluorescent chemokines were produced in the laboratory by
expressing CXCL12 tagged at the C-terminus with fluorescent
proteins in insect cells (E.C. and M.T., unpublished). Hearts of
wild-type mice (BALB/c) were excised, and heart tips were
removed to access the ventricles. After rinsing with DPBS, 2%
FBS, LiqueminH (Roche) the specimens were incubated with
fluorescent chemokine as described above. For confocal micros-
copy of the cryosections, nuclei of fixed and permeabilized
cryosections were stained with DAPI.
Statistical Analysis
All statistical analyses were performed using SigmaPlot software
(Systat Software). Statistical comparisons between datasets were
made with Student’s t-test.
Results
We previously reported that CXCL12-induced internalization
of CXCR7 is inconsistent between primary circulating human
CD19+ B cells and mouse pre 300.19 B cells stably expressing the
receptor [10]. The chemokine induces CXCR7 internalization in
transfected cells, but has little effect on the level of surface receptor
expression on primary B cells. Similar lack of CXCR7 down-
regulation after CXCL12 treatment was observed in other cells
which express endogenous CXCR7, such as monocytes, the
monocytic cell line THP-1, B cell clones and tumor derived cells.
We now reiterated this observation in more detail using Daudi
(Figure 1A) and Raji cells which express endogenous CXCR4 and
CXCR7 at the plasma membrane [10]. Receptor surface
expression was determined with specific monoclonal antibodies
by FACS analysis. Bound chemokine, which could prevent
antibody binding, was efficiently removed by an acidic wash prior
antibody application [25]. In agreement with previous reports
stimulation of the cells with CXCL12 induces a concentration-
dependent disappearance of CXCR4 from the cell surface (not
shown) [25,26]. Figure 1B shows the maximum internalization of
CXCR4 and CXCR7 which was induced by CXCL12 treatment.
Approx. 50% of CXCR4 became internalized after 20 min and
down-regulation increased to about 70–80% (75%610% SD)
after 1 h (Figure 1B). By contrast, little overall internalization (10–
25%) of CXCR7 was detected after 60 min. However, at early
time points after CXCL12 addition a transient CXCR7 down-
regulation was observed which showed a maximum (up to 40%)
after 10 min and recovered thereafter. The time course with a
minimum at 10 min was consistently observed in Daudi and Raji
cells (Figure 1B). The finding suggests that CXCR7 expression at
the cell surface is tightly regulated and the receptor is rapidly
replenished from intracellular stores after an initial agonist-
induced internalization. Indeed CXCR7 expression fully recov-
ered after removal of the chemokine and incubation at 37uC for
30 min. By contrast CXCR4 expression remained down regulated
under these conditions (Figure 1C). Bafilomycin A is a well
established inhibitor of vATPases, which mediates the gradual
acidification of organelles going from the cell surface to lysosomes
[27–29]. Treatment of Daudi cells with bafilomycin A had no
effect on ligand-induced CXCR4 down regulation and CXCL12
induced CXCR7 internalization (Figure 1C). However, recycling
of CXCR7 was markedly attenuated, suggesting that lowering the
pH in the lumen of the endosome is required for the dissociation of
CXCL12 from CXCR7 and thereby promoting subsequent
receptor recycling to the plasma membrane. Receptor de novo
synthesis during the course of the experiments was excluded by the
presence of the translation inhibitor cycloheximide.
We therefore hypothesized that CXCR7 acts as a scavenger
for CXCL12. To this end Madin-Darby canine kidney (MDCK)
epithelial cells were stably transfected with CXCR7, CXCR4,
or CXCR7 lacking the cytoplasmic C terminus (DCXCR7).
Because CXCR7 does not trigger pertussis toxin sensitive
responses [8], we created also a chimeric receptor where we
replaced the DRYLSIT-sequence in the second intracellular
loop of CXCR7 with the corresponding DRYLAIV-sequence
from CXCR4. This sequence is considered critical for
functional coupling of GPCRs to Gi-proteins [8,30]. Restoration
of the motif in the scavenger D6 confers weak ligand-induced
signaling activity [31]. The expression of all receptors on the cell
surface was confirmed by FACS analysis (Figure 2A). The
chimeric CXCR7 was expressed to a similar level as its wild type
counterpart (Figure 2A). Nevertheless, introduction of the
canonical DRYLAIV motif into CXCR7 instead of DRYLSIT
did not result in CXCL12-inducible chemotaxis, calcium
mobilization, or ERK activation when expressed in either
MDCK cells or 300.19 pre-B cells (not shown). Confocal
microscopy of permeabilized MDCK cells revealed a marked
punctuated staining arising from below the cell surface,
suggesting that a large fraction of both receptors resides on
intracellular compartments (Figure 2B).
CXCR7 Scavenges CXCL12
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The scavenging activity of CXCR7 was measured using
transfected MDCK cells seeded on TranswellH insets and grown
to confluence. Radiolabeled [125I] CXCL12 was then added to the
upper compartment and the cells incubated for 3 h at 37uC. To
distinguish between degraded CXCL12 and intact or only
partially proteolysed chemokine trichloroacetic acid (TCA) was
added to the medium collected from the upper and lower
compartment as well as the cell lysate to precipitate proteins.
Radioactivity that is insensitive to TCA precipitation reflects
chemokine that was cleaved by the cells during the incubation
time. We compared the efficiency of MDCK cells expressing
similar levels of CXCR7 and CXCR4 (Figure 2A) to degrade
CXCL12. Cells expressing CXCR7 secreted significantly more
CXCL12-derived radioactivity into the lower compartment than
their CXCR4+ counterparts (Figure 3A). With either receptor the
majority of the radioactivity was insensitive to TCA treatment,
indicating that CXCL12 becomes largely degraded. Similar
amounts of cleaved CXCL12 were also detected in the upper
compartment of the transwell. We therefore summed all TCA-
sensitive radioactivity recovered from the bottom of the well, in the
cell lysate and from the upper well to calculate the total
degradation activity (Figures 3B–F). We could not find evidence
that the small fraction of TCA-sensitive radioactivity, which was
transcytosed from the apical to the basal side by CXCR7,
contained biological activity.
Over the concentration range tested (0.25 nM–25 nM
CXCL12) CXCR7 mediated pronounced degradation of the
chemokine as opposed to CXCR4. The difference of the two
receptors in promoting the proteolysis was most evident at 25 nM
CXCL12. Noteworthy, the reported binding affinity of CXCL12
for CXCR7 (Kd , 0.2–0.4 nM) is considerably higher than for
CXCR4 (Kd , 2–4 nM) [5,7,32]. However, when the CXCL12
concentration in the assay was raised up to 100 times the Kd the
capacity of CXCR7 to mediate degradation of the chemokine
appeared not to be saturated, but rather increased linearly. By
contrast, the effectiveness of CXCR4 to mediate proteolysis of
CXCL12 showed a maximum at 2.5 nM and did not further
augment at 25 nM (Figure 3B). The more prominent CXCR4
internalization shown in figure 1, contrasts the more efficient
processing of CXCL12 by CXCR7. The apparent discrepancy is
best explained with a scavenger function of CXCR7. In this model
the receptor continuously cycles between the plasma membrane
and an intracellular compartment, where the chemokine is
delivered for degradation and CXCR7 returns to the membrane
at the cell surface. In this way the receptor can efficiently clear
CXCL12 from the external medium. Contrarily, CXCR4 upon
ligand binding is internalized and becomes to a large extent
degraded [25,26,33].
The second reported ligand for CXCR7 is CXCL11. Indeed,
MDCK cells expressing CXCR7 degraded [125I] CXCL11
(Figure 3C) although with lower efficiency. Nevertheless, CXCL11
readily competed proteolysis of CXCL12 by CXCR7 (Figure 3D)
and, as predicted from the known receptor specificity, CXCL11
had no effect on the moderate CXCR4 mediated CXCL12
degradation. Conversely, addition of a 100 fold excess of
unlabelled CXCL12 expectedly attenuated the uptake and
degradation of radiolabeled ligand of both receptors (not shown).
The results underline specificity of CXCR7 to scavenge CXCL12.
Two small molecule inhibitors of CXCR4, AMD3100 (10 mM)
and NIBR-1816 (10 mM) [34,35] markedly reduced the degrada-
tion by CXCR4, but had no effect on CXCR7 mediated
scavenging of CXCL12. The data indicate further that binding
and internalization of cognate chemokine by CXCR7 and
CXCR4 are independent of each other.
Figure 3E shows that MDCK cells expressing CXCR7 when
exposed to 0.25 nM [125I]-CXCL12 degraded approx. 30% of the
added chemokine. By contrast, in cells transfected with an empty
plasmid (mock) only marginal background proteolysis was
observed. Cells carrying CXCR4 displayed a markedly reduced
capacity to degrade CXCL12 compared with CXCR7. Exchang-
ing the DRY-motif with the sequence of CXCR4 had no effect on
CXCR7-mediated degradation, suggesting that this motif is not
critical for the activity of the receptor. By contrast, deletion of the
intracellular C-terminus (DCXCR7) completely abolished
CXCL12 degradation mediated by CXCR7 (Figure 3F), suggest-
ing that the domain is required for trafficking of the receptor.
Figure 1. CXCL12 induced internalization of CXCR7 and CXCR4. (A) FACS analysis of resting Daudi B cells expressing endogenous CXCR4 and
CXCR7. (B) Summary from three independent observations showing the time course of receptor expression of Daudi B cells expressing endogenous
CXCR4 (open symbols) and CXCR7 (closed symbols) incubated with 100 nM (circles) or 1 mM (triangles) CXCL12. Extracellular bound chemokine was
removed by an acidic wash (see Methods) and receptor surface expression was measured at the indicated times by FACS analysis. P,0.5 for ligand-
induced internalization of CXCR7 and CXCR4. (C) Daudi B cells were incubated for 1 h at 37uC with 250 nM CXCL12. Extracellular bound chemokine
was removed by an acidic wash and samples were split. Surface expression of CXCR7 (closed symbols) and CXCR4 (open symbols) was measured by
FACS analysis directly (609 internalization), or following an additional incubation for 30 min at 37uC to allow receptor reexpression (+309 recycling).
DMSO vehicle (circles) and 2 mM Bafilomycin A1 (triangles) were present during the entire procedure and a 60 min pre-treatment of the cells. MFIs are
shown as percent of DMSO control without chemokine. Data from three independent observations; * P,0.05.
doi:10.1371/journal.pone.0009175.g001
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From the above experiments it is not clear if cycling of CXCR7
from the plasma membrane to endosomes is ligand induced or
may also occur constitutively. To address this question we
measured the dynamics of CXCR4 and CXCR7 expression at
the plasma membrane in the absence of chemokines. Daudi cells
or MDCK cells stably transfected with CXCR7 or CXCR4 were
treated on ice with proteinase K. The protease is active at the low
temperature, although with delayed kinetics, but membrane
trafficking is completely abrogated [36]. Proteinase K cleaves the
N-termini which contain the epitopes of CXCR7 for the mAb 9C4
Figure 2. Ectopic expression of CXCR7 and CXCR4 on MDCK cells. (A) MDCK were stably transfected with empty vector (Mock), with CXCR7,
CXCR4, a vector coding for a CXCR7 lacking the cytoplasmic C-terminus (DCXCR7), and a vector coding for a chimeric CXCR7 containing the DRYLAIV
motive of CXCR4. Receptor expression was determined by FACS analysis using saturating antibody concentrations (see Methods). (B) Confocal
immunofluorescence analysis of unfixed MDCK cells expressing CXCR7 (upper panels) or CXCR4 (lower panels). Cells also expressed N-ter-Lck
mCherry as membrane marker (red fluorescence). Left panels: confocal images of planes cut through intracellular regions of MDCK monolayers. Right
panels: x-z planes reconstructed from confocal x-y stacks. For receptor (green) detection anti-CXCR7 (11G8 R&D) or anti CXCR4 (MAB173 R&D) were
used. Receptor-bound primary antibodies were revealed with goat anti mouse IgG conjugated with Alexa488 (green fluorescence).
doi:10.1371/journal.pone.0009175.g002
CXCR7 Scavenges CXCL12
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[5] and of CXCR4 for the mAb 6H8 [24]. Following removal of
the protease the cells were shifted to 37uC in the presence of
cycloheximide. Re-emerging of the respective receptor epitopes
was measured by FACS analysis. Figure 4A shows that in MDCK
cells CXCR7 rapidly reappeared after shifting to 37uC reaching
an expression level of 60% after one hour compared to that
measured on untreated control cells. By contrast, after one hour of
incubation at 37uC the immunoreactive CXCR4 was about 20%
of control. In Daudi cells the reappearance after proteinase K
treatment of endogenous CXCR4 and CXCR7 was compared
with a typical ligand-independent cycling receptor, the transferrin
receptor. After 20 min, the surface levels of the transferrin
receptor were fully restored and expression of CXCR7 recovered
by 50%. Conversely, during the same time CXCR4 levels reached
only 20%. Together the findings suggest an intermediate cycling
activity for CXCR7 which is less rapid compared with the
transferrin receptor, but markedly faster than CXCR4, consistent
with the more pronounced degradation of CXCL12 mediated by
CXCR7.
Ligand independent cycling of CXCR7 was further investigated
with antibody uptake experiments. MDCK cells expressing
CXCR7 or CXCR4 were incubated for 1 h at 37uC in the
absence of chemokines with specific monoclonal antibodies known
to block receptor function (9C4 and 12G5, respectively) [5,37].
Following removal of extracellular antibodies by stringent
washing, cells were fixed and immunecomplexes detected with
F(ab9)2 goat anti mouse IgG Alexa488 by confocal microscopy. In
CXCR7 expressing MDCK cells a pronounced intracellular
staining was observed which is associated with endosomal
compartments. By contrast, CXCR4+ cells contained much less
fluorescent endosomes (Figure 4C). The marked antibody uptake
in CXCR7+ cells in the absence of stimulation suggest spontane-
ous receptor cycling between the plasma membrane and
endosomal compartments. To further verify ligand-independent
Figure 3. Degradation of CXCL12 mediated by CXCR7 and CXCR4. (A) MDCK cells stably transfected with empty vector (Mock), with CXCR7,
and CXCR4 were incubated with 0.25 nM [125I]-CXCL12 for 3 h at 37uC added to the apical side. Black bars, TCA resistant radioactivity recovered from
the lower part of the transwell; grey bars, radioactivity which was precipitated with TCA. Data from 5 experiments performed in triplicates. (B)
Degradation of CXCL12 mediated by CXCR7 is not saturated by increasing concentrations of ligand. MDCK cells stably expressing CXCR7 or CXCR4
were incubated with increasing concentrations of [125I]-CXCL12 as in (A). Total TCA resistant counts were used to calculate the amount of degraded
chemokine. Representative data shown from one experiment performed in triplicates. (C) MDCK stably transfected with empty vector (Mock) or
CXCR7 were exposed to 0.25 nM [125I]-CXCL11 as in B. In three independent experiments more pronounced spontaneous degradation of CXCL11 in
Mock-transfected cells compared to CXCL12 degradation was observed. (D) MDCK stably transfected with empty vector (Mock), with CXCR7, and
CXCR4 were exposed to 0.25 nM [125I]-CXCL12 as in A in the presence of medium (cont.), 1 mM CXCL11 or the CXCR4 inhibitors AMD3100 (10 mM) and
NIBR-1816 (10 mM). (E) The DYLAIV motif is not critical for CXCR7 activity. MDCK stably transfected with empty vector (Mock), with CXCR7, CXCR4 and
a vector coding for a chimeric CXCR7 containing the DRYLAIV motive of CXCR4 were incubated as in B. Data from experiments that were performed
in triplicates (n = 5, except DRYLAIV n = 2). (F) MDCK stably transfected with empty vector (Mock), with CXCR7, or a vector coding for a CXCR7 lacking
the cytoplasmic C terminus (DCXCR7) were exposed to [125I]-CXCL12 as in B.
doi:10.1371/journal.pone.0009175.g003
CXCR7 Scavenges CXCL12
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receptor cycling MDCK cells expressing CXCR4,CXCR7 or
DCXCR7 were incubated with the respective antibodies at 0uC.
Excess of antibody was removed and the cells shifted to 37uC in
the presence of cycloheximide. Detection of the primary
antibodies bound to surface-expressed receptors by FACS analysis
revealed a rapid time dependent decrease of CXCR7 (Figure 4D).
The loss of primary antibody from the cell surface is in agreement
with ligand-independent internalization of CXCR7. Cells express-
ing DCXCR7 showed a marginal loss of primary antibody from
the cells surface over time, in accordance with the notion that
DCXCR7 does not internalize upon ligand exposure [5] and the
failure of mediating CXCL12 degradation (Figure 3D). As
expected primary antibody bound to CXCR4 expressed on the
plasma membrane decreased only marginally consistent with the
negligible spontaneous internalization. As both, ligand indepen-
dent cycling and CXCL12-induced receptor internalization
Figure 4. Ligand-independent receptor cycling. (A) MDCK cells expressing CXCR7 or CXCR4 were treated on ice with proteinase K to eliminate
receptor epitopes from the surface. Cells were washed and incubated at 37uC in medium. At the indicated times aliquots were removed from the
incubation and receptor surface expression measured by FACS analysis. (B) Daudi B cells expressing endogenous CXCR7, CXCR4, and transferrin
receptor were treated with proteinase K as in (A), and subjected to FACS analysis. (C) MDCK cells expressing membrane-anchored mCherry (red color)
and CXCR7 or CXCR4 were incubated with receptor specific monoclonal antibodies at 37uC for 30 min. Cells were fixed, permeabilized and stained
with goat anti-mouse F(ab)2 Alexa 488. Red: Actin stained with Alexa Fluor 594 phalloidin; blue Nuclei stained with DAPI. Ligand-independent
receptor internalization was visualized by confocal microscopy. Representative data shown from one experiment out of 5. (D) MDCK cells expression
CXCR7, CXCR4, or a vector coding for a CXCR7 lacking the cytoplasmic C terminus (DCXCR7) were incubated on ice with receptor-specific antibodies.
After removal of unbound antibodies cells were shifted to 37uC. At the indicated times aliquots were withdrawn and incubated with secondary goat
anti-mouse F(ab)2 Alexa 488 at 0uC. Receptor surface expression was measured by FACS analysis.
doi:10.1371/journal.pone.0009175.g004
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(Figure 1) can be observed for CXCR7 it is conceivable that the
two mechanism work synergistically or at least act in parallel. As a
whole our findings are in full agreement with the conclusion that
CXCR7 expressed on MDCK cells acts as specific decoy for
CXCL12 and CXCL11.
In zebrafish contradicting opinions on the role of CXCR7 have
been reported, suggesting a signaling [17] versus a scavenger
function [19]. To investigate this controversy, we followed the
subcellular localization of the receptor in zebrafish cells. CXCR7-
EGFP (CXCR7 tagged at the C-terminus with EGFP) was
expressed in embryos alone or in combination with a morpholino
oligonucleotide suppressing CXCL12 expression [19,21]. Figure 5
shows frames from time-lapse movies (Supplementary Informa-
tion, movies S1 (control - MO) and S2 (CXCL12-MO)) which
document the spontaneous pinching off from the plasma
membrane of CXCR7 containing endosomes and their re-
association with the membrane. The movement of CXCR7
appears independent of the presence of CXCL12 indicating that
CXCR7 can, in agreement with its proposed scavenger function,
spontaneously cycle from and back to the plasma membrane in
zebrafish embryonic cells. Boldajipour et al. [19] proposed that by
removing CXCL12 at the posterior side CXCR7 sharpens the
chemotactic gradient promoting CXCR4-dependent migration of
primordial germ cells. The present observation provides an
explanation for the efficiency of CXCR7 in supporting CXCR4-
mediated migration of primordial germ cells and is consistent with
the view that CXCR7 that is expressed by somatic cells functions
as a scavenger.
Targeted deletion of Cxcr7 leads to perinatal death with a
marked cardiac phenotype that is associated with septum and
heart valve malformation. The phenotype is also manifest upon
conditional deletion of Cxcr7 in endothelium [9]. A possible
explanation for the phenotype could be that lack of CXCR7 gives
rise to CXCL12-stimulated CXCR4-dependent hyperplasia. We
therefore tested if mouse heart valves can scavenge CXCL12.
Hearts were removed from wild type laboratory (BALB/c) mice
and cut transversally. The opened hearts which included all valves
were incubated with 150 nM CXCL12 tagged at the C-terminus
with the fluorescent protein mCherry. Frozen sections of the hearts
reveal endosomes in valve endothelial cells loaded with CXCL12-
mCherry. Uptake was marginally impaired in the presence of
10 mM AMD3100, suggesting that the process is mediated by
CXCR7 rather than by CXCR4. In line with this a recent report
indicates that AMD3100 at 10 mM slightly affects CXCL12
binding to CXCR7 [38]. Addition of 1.5 mM untagged CXCL12
expectedly competed the uptake of CXCL12-mCherry (Figure 6).
The results are consistent with a scavenger activity of CXCR7 on
valve endothelium in adult mice.
Human umbilical cord endothelial cells (HUVECs) express
CXCR4 and CXCR7 [7,39]. To test the scavenging activity of
Figure 5. Ligand-independent cycling of CXCR7 in zebrafish embryos. In embryos expressing CXCR7-EGFP the receptor localizes at the
plasma membrane (grey mark in lower panels) and intracellular vesicles (white dot). Time laps (time stamps) images shows that the vesicles are in
contact with the membrane internalize and recycle back to the membrane. Internalization and cycling of CXCR7-EGF is similar in the presence
(control–MO) or absence of CXCL12 (CXCL12–MO), underling the ligand independent mechanism. For the complete time laps see supplementary
movies S1 cont and S2 CXCL12.
doi:10.1371/journal.pone.0009175.g005
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CXCR7 expressed on these cells, early passage HUVECs were
incubated with [125I]-CXCL12 for 3 h at 37uC. Figure 7A shows
that HUVECs proteolyzed nearly 30% of the added chemokine.
Degradation was marginally inhibited by AMD3100 (10 mM), but
efficiently competed by 1 mM CXCL11, suggesting proteolysis is
largely attributed to CXCR7-dependent scavenging. CXCR7 is
expressed on human vascular endothelium and is further
upregulated by inflammatory cytokines such as TNFa or IL-1b
[7,40]. To reveal a potential scavenging activity of CXCR7 on
primary human tissue we incubated fresh human umbilical cord
slices with CXCL12 tagged at the C-terminus with fluorescent
protein Venus. Figure 7B (upper left) shows the expression of
CXCR7 at the lining endothelium of the umbilical veins.
Incubation of the slices with 200 nM CXCL12-Venus causes the
appearance of fluorescent endosomes, suggesting the uptake of the
chemokines by surface receptors (upper right). Pretreatment of the
slices with 10 mM AMD3100 for 10 min had no effect on the
uptake. By contrast, addition of 1.5 mM CXCL11 fully competed
the uptake of CXCL12. The data are in accordance with the
observations made with HUVECs and substantiate the conclusion
that CXCR7 acts as scavenger on human endothelial cells.
Figure 7C summarizes data obtained with umbilical cords from
different donors. Although a notable donor to donor variation is
visible, the statistical analysis reveals CXCL11-sentive uptake of
CXCL12, which is marginally affected by AMD3100, supporting
the view that CXR7 acts as a scavenger in endothelial cells.
Discussion
The tight regulation of the surface expression of CXCR7 in the
presence of CXCL12 suggests that the receptor functions a
scavenger. Biochemical analysis in MDCK cells and HUVECs
Figure 6. Uptake of CXCL12 by mouse heart valve. The aortic
heart valves of wild type mice internalize CXCL12 tagged with a
fluorescent protein (CXCL12-mCherry, upper right, red dots marked
with arrowheads). Uptake of CXCL12-mCherry is partially competed
with unlabeled 1.5 mM CXCL12 (lower left), and is partially resistant to
administration of 10 mM AMD3100 (lower right). Pictures were taken in
the indicated area (white frame upper left).
doi:10.1371/journal.pone.0009175.g006
Figure 7. Scavenging activity of CXCR7 in primary human endothelium. (A) Human umbilical vein endothelial cells (HUVECs) were exposed
for 3 h at 37uC to [125I]-CXCL12 in the presence of 1 mM CXCL11 or 10 mM of the CXCR4 inhibitor AMD3100. TCA resistant counts represent degraded
chemokine and were plotted as percent of total added counts (cont). (B) Vein endothelial cells in fresh human umbilical cord slices express CXCR7
(purple upper left, blue nuclei DAPI), vein endothelial cells (CD31 marker red) internalize CXCL12 tagged with a fluorescent protein (CXCL12-venus,
upper right, green dots marked with arrowheads), uptake of CXCL12-venus is not affected by 10 mM AMD3100 (lower left), but is competed with
1.5 mM CXCL11 (lower right). (C) Several images (5126512 pixels) from 3 independent experiments as shown in (B) were analyzed using Metamorph
software. Total pixel areas showing fluorescence of the CXCL12-venus per image are shown. P,0.05 between cont. and CXCL11, not significant
between cont. and AMD3100.
doi:10.1371/journal.pone.0009175.g007
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reveal an effective capacity of CXCR7 to eliminate CXCL12 from
its surrounding environment. The efficiency of scavenger receptors
depends on their capability to mediate the elimination of a
stoichiometric multiplicity of ligands from the surrounding
environment. In figure 3B we demonstrate that degradation of
CXCL12 by CXCR7 is not saturated even at elevated chemokine
concentrations.
Heptahelical receptors have been described which bind
chemokines with high affinity, but fail to couple to heterotrimetric
G-proteins and to induce typical responses. In mammalians three
‘atypical’ chemokine receptors were characterized namely the
Duffy antigen receptor for chemokines (DARC), D6, and CCX-
CKR (CCR11). DARC has recently been shown to transcytose
inflammatory chemokines from the basal to the luminal site of the
venular endothelium. Since chemokines remain bound to DARC
expressed in the lumen of venules the receptor supports chemokine
migratory activity and leukocyte extravasation [41]. On erythro-
cytes DARC is assumed to function as sink or reservoir for many
inflammatory chemokines [42]. The primary function of D6 and
CCX-CKR is to act as scavenger for chemokines. D6 contributes
to the resolution of inflammation by internalizing and destroying
inflammatory CC chemokines [43,44]. CCX-CKR effectively
internalizes the homeostatic CC chemokines CCL19 and CCL21
targeting them for degradation [45]. However, CXCL12 does not
bind to any of the ‘atypical’ receptors.
Like the other decoy receptors for chemokines CXCR7 does not
activate heterotrimeric G-proteins, a compulsory step for typical
signal transduction of heptahelical receptors [8,46]. Nevertheless,
internalization of this class of receptors does not require coupling
to G-proteins. Recently it was reported that CXCL12 induces
arrestin binding to CXCR7, indicating that the agonist can
promote internalization through clathrin coated pits [38]. In line
with this observation we found that deletion of the C-terminus of
CXCR7 markedly reduces scavenger activity (Figure 3D and 4D).
Exceptionally among chemokine receptors CXCR4 can induce
the sustained activation of the PI 3-kinase/PKB and MAPK
cascade [46]. This responsiveness may contribute to the
proliferative and pro-survival characteristics of the CXCL12/
CXCR4 axis [47,48]. Depending on the context, however, the
properties can be detrimental for the host organism und must
therefore be under tight control. The prolonged signaling by
CXCR4 demands the continuous presence of CXCL12 at the cell
surface and is abrogated when the chemokines becomes degraded,
e.g. by CD26/dipeptidyl peptidase IV [26,49,50]. Blocking of the
CXCL12/CXCR4 signaling axis leads to the proliferation of
primitive hematopoietic stem cells [51] while excessive signaling
by CXCR4 accounts for the molecular pathoetiology of the
WHIM syndrome [52] and is associated with tumor growth and
metastasis formation [53]. These observations indicate that the
level and availability of CXCL12 for CXCR4 is tightly regulated
under normal conditions and the present data indicate that
CXCR7, which is widely expressed, may critically contribute to
this regulation.
An alternative regulation of CXCR4 activity by CXCR7 could
be potential heterodimerization of the receptors. Co-transfection
of CXCR7 and CXCR4 in HEK cells indicates that the receptors
can functionally heterodimerize [9,15]. However, in primary
human CD19+ B cells, which express both receptors in circulation,
co-internalization, a hall mark of heptahelical receptor dimers, was
not observed, suggesting that heterodimerization in primary cells is
of minor relevance [1,10].
The perinatal lethality of mice with a deletion of Cxcr7 [9,54]
could be explained by the lack of CXCL12 scavenging in these
animals. Platelets which carry large amounts of CXCL12 may
deploy the chemokine when undergoing mechanical stress in the
heart circulation. The excessive presence of the chemokine may
subsequently stimulate CXCR4 which is highly expressed on the
heart endothelium (MT, unpublished), leading to aberrant
proliferation [55]. Such view is also in line with the expression
of CXCR7 on the heart valves of adult mice. The evolutionary
conserved mechanism of CXCL12 scavenging by CXCR7 further
supports the importance of this activity [19]. In a previous study,
when CXCR7 as receptor for CXCL12 was not yet disclosed,
scavenging of CXCL12 by endothelial CXCR4 was proposed,
which was partially attenuated in the presence of CXCR4
inhibitors. The authors further suggested that CXCR4 translo-
cates CXCL12 to the bone marrow [56]. Whether CXCR7 can
transcytose CXCL12, in analogy to the activity of DARC [41],
remains to be established. The present findings, however, fully
support the conclusion that the principal function of CXCR7 is to
act as scavenger for CXCL12.
Supporting Information
Movie S1 Cont Ligand-independent cycling of CXCR7 in
zebrafish embryos. In embryos expressing CXCR7-EGFP the
receptor localizes at the plasma membrane (grey) and intracellular
vesicles (blue dot). Time laps shows that the vesicles are in contact
with the membrane internalize and recycle back to the membrane.
Internalization and cycling of CXCR7-EGF in the presence
(control - MO) of CXCL12.
Found at: doi:10.1371/journal.pone.0009175.s001 (4.61 MB
MOV)
Movie S2 CXCL12 Ligand-independent cycling of CXCR7 in
zebrafish embryos. In embryos expressing CXCR7-EGFP the
receptor localizes at the plasma membrane (grey) and intracellular
vesicles (blue dot). Time laps shows that the vesicles are in contact
with the membrane internalize and recycle back to the membrane.
Internalization and cycling of CXCR7-EGF in the absence of
CXCL12 (CXCL12 - MO).
Found at: doi:10.1371/journal.pone.0009175.s002 (3.27 MB
MOV)
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